Pacira BioSciences Company Insiders

Pacira BioSciences Management Team Effectiveness

The company has return on total asset (ROA) of 0.0289 % which means that it generated a profit of $0.0289 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.029 %, meaning that it created $0.029 on every $100 dollars invested by stockholders. Pacira BioSciences' management efficiency ratios could be used to measure how well Pacira BioSciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.08 in 2026. Return On Capital Employed is likely to drop to -0.06 in 2026. At this time, Pacira BioSciences' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 976.1 M in 2026, whereas Other Assets are likely to drop 1.09 in 2026. Net Income Applicable To Common Shares is likely to rise to about 19.2 M in 2026, whereas Common Stock Shares Outstanding is likely to drop slightly above 36.8 M in 2026. The majority of Pacira BioSciences outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Pacira BioSciences to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Pacira BioSciences. Please pay attention to any change in the institutional holdings of Pacira BioSciences as this could imply that something significant has changed or is about to change at the company. Some institutional investors establish a significant position in stocks such as Pacira BioSciences in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Pacira BioSciences, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Pacira BioSciences Workforce Comparison

The company has Profit Margin (PM) of 0.03 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.

Pacira BioSciences Insider Trading History

Pacira BioSciences Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Pacira BioSciences often depends on how effective the management is. Pacira BioSciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pacira management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pacira management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Pacira BioSciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Pacira BioSciences. Check Pacira BioSciences' Beneish M Score to see the likelihood of Pacira BioSciences' management manipulating its earnings.

When running Pacira BioSciences' price analysis, check to measure Pacira BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences is operating at the current time. Most of Pacira BioSciences' value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences' price. Additionally, you may evaluate how the addition of Pacira BioSciences to your portfolios can decrease your overall portfolio volatility.